Abbott Laboratories (ABT)
93.93
-0.47
(-0.50%)
USD |
NYSE |
Jul 10, 16:00
94.10
+0.17
(+0.18%)
After-Hours: 20:00
Abbott Laboratories Cash from Investing (Quarterly) : -20.32B for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -20.32B |
| December 31, 2025 | -913.00M |
| September 30, 2025 | -457.00M |
| June 30, 2025 | -582.00M |
| March 31, 2025 | -470.00M |
| December 31, 2024 | -866.00M |
| September 30, 2024 | -594.00M |
| June 30, 2024 | -453.00M |
| March 31, 2024 | -425.00M |
| December 31, 2023 | -824.00M |
| September 30, 2023 | -634.00M |
| June 30, 2023 | -1.213B |
| March 31, 2023 | -462.00M |
| December 31, 2022 | -632.00M |
| September 30, 2022 | -484.00M |
| June 30, 2022 | -264.00M |
| March 31, 2022 | -360.00M |
| December 31, 2021 | -671.00M |
| September 30, 2021 | -651.00M |
| June 30, 2021 | -264.00M |
| March 31, 2021 | -422.00M |
| December 31, 2020 | -731.00M |
| September 30, 2020 | -472.00M |
| June 30, 2020 | -619.00M |
| March 31, 2020 | -393.00M |
| Date | Value |
|---|---|
| December 31, 2019 | -489.00M |
| September 30, 2019 | -432.00M |
| June 30, 2019 | -498.00M |
| March 31, 2019 | -396.00M |
| December 31, 2018 | -496.00M |
| September 30, 2018 | -323.00M |
| June 30, 2018 | -299.00M |
| March 31, 2018 | -238.00M |
| December 31, 2017 | -3.152B |
| September 30, 2017 | -306.00M |
| June 30, 2017 | -6.00M |
| March 31, 2017 | -6.154B |
| December 31, 2016 | 1.55B |
| September 30, 2016 | -554.00M |
| June 30, 2016 | -1.47B |
| March 31, 2016 | 226.00M |
| December 31, 2015 | 1.566B |
| September 30, 2015 | -1.197B |
| June 30, 2015 | 242.00M |
| March 31, 2015 | -205.00M |
| December 31, 2014 | -10.00M |
| September 30, 2014 | -825.00M |
| June 30, 2014 | 1.228B |
| March 31, 2014 | -595.00M |
| December 31, 2013 | 839.70M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Becton, Dickinson & Co. | -192.00M |
| Boston Scientific Corp. | -591.00M |
| DexCom, Inc. | -298.50M |
| Insulet Corp. | -27.70M |
| Intuitive Surgical, Inc. | -914.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.315B |
| Cash from Financing (Quarterly) | 17.31B |
| Free Cash Flow | 7.378B |
| Free Cash Flow Per Share (Quarterly) | 0.5243 |
| Free Cash Flow to Equity (Quarterly) | -19.00B |
| Free Cash Flow to Firm (Quarterly) | 993.30M |
| Free Cash Flow Yield | 4.49% |